Description
OMEMEXA-D combines Omeprazole 20 mg and Domperidone 10 mg in capsule form. Omeprazole reduces gastric acid production, while Domperidone helps manage nausea and vomiting by influencing gastrointestinal motility. Therefore, healthcare professionals may consider this combination for selected gastrointestinal conditions where acid suppression and control of nausea or vomiting both matter.
For related formulations and therapeutic segments, explore the Medhexa Pharma product range for pharmaceutical formulations and business opportunities.
Therapeutic Segment
Gastrointestinal Care | Acid Suppression | Proton Pump Inhibitors | Nausea & Vomiting Management | Digestive Care
Uses of OMEMEXA-D
OMEMEXA-D may support treatment plans for selected gastrointestinal conditions when a healthcare professional considers both ingredients appropriate.
The Omeprazole component helps manage acid-related conditions such as:
- Gastroesophageal reflux disease (GERD)
- Heartburn and acid-related symptoms
- Acid-mediated gastrointestinal conditions
- Certain gastric and duodenal ulcer conditions
Meanwhile, Domperidone primarily helps relieve nausea and vomiting. Regulatory guidance does not support routine long-term Domperidone use for heartburn, dyspepsia or GERD alone because evidence for those uses remains limited.
Key Benefits of OMEMEXA-D
- Combines Omeprazole 20 mg and Domperidone 10 mg in one capsule.
- Omeprazole reduces gastric acid production.
- Consequently, it can help manage acid-related symptoms such as heartburn and reflux.
- Domperidone can help relieve nausea and vomiting when its use is appropriate.
- The combination provides two complementary actions within one dosage form.
- The product comes in 10 × 15 Aluminium-Strip packaging.
How OMEMEXA-D Works
First, Omeprazole works as a proton pump inhibitor (PPI). It blocks the H+/K+-ATPase proton pump in the stomach’s acid-producing cells. As a result, the stomach releases less acid, which helps control acid-related symptoms and supports healing in certain acid-mediated conditions.
Meanwhile, Domperidone blocks dopamine receptors and influences gastrointestinal activity. It can improve upper gastrointestinal motility and help control nausea and vomiting.
Together, the two ingredients provide acid suppression alongside nausea and vomiting management when a healthcare professional considers the combination suitable.
Common Side Effects of OMEMEXA-D
Some patients may experience:
- Headache
- Abdominal discomfort
- Stomach pain
- Nausea
- Diarrhoea
- Constipation
- Flatulence
- Dry mouth
- Dizziness
Domperidone can also cause movement-related effects in some patients. However, the risk and severity of side effects vary from person to person.
If symptoms persist, become severe or concern you, contact a healthcare professional rather than changing the dose yourself.
Important Safety Information
Use OMEMEXA-D only according to the advice of a qualified healthcare professional.
Domperidone requires particular attention to heart-related safety. It can prolong the QT interval and, in rare cases, contribute to serious ventricular arrhythmias. The risk increases in people over 60 years of age, with higher daily doses and when patients take medicines that prolong the QT interval or strongly inhibit CYP3A4.
Therefore, patients with known QT prolongation, significant electrolyte disturbances, bradycardia or certain underlying heart conditions should not use Domperidone. It also has important interactions with certain QT-prolonging medicines and potent CYP3A4 inhibitors.
Before starting treatment, tell your healthcare professional about heart disease, liver problems, electrolyte abnormalities and all medicines or supplements you currently take.
Omeprazole can also interact with certain medicines. In addition, prolonged PPI treatment may increase the risk of problems such as vitamin B12 deficiency, low magnesium levels, bone fractures and certain kidney-related reactions.
For authoritative safety information, refer to the European Medicines Agency information on Domperidone-containing medicines.
Dosage & Administration
Follow the dose and treatment duration prescribed by your healthcare professional.
Domperidone should generally be used at the lowest effective dose for the shortest appropriate duration. European regulatory guidance recommends oral Domperidone primarily for nausea and vomiting and limits treatment duration to one week in the relevant adult recommendations.
Take OMEMEXA-D exactly as directed. Swallow the capsule with water and follow the administration instructions provided with the product.
Do not increase the dose, stop treatment or extend the course without medical advice.
Storage
- Store in a cool, dry place.
- Keep the product away from excessive heat and moisture.
- Protect the capsules from direct sunlight.
- Keep the capsules in their original packaging until use.
- Keep out of reach of children.
- Follow the storage conditions printed on the product packaging.
